RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
- PMID: 7518356
- DOI: 10.1016/0092-8674(94)90570-3
RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
Abstract
The immunosuppressants rapamycin and FK506 bind to the same intracellular protein, the immunophilin FKBP12. The FKB12-FK506 complex interacts with and inhibits the Ca(2+)-activated protein phosphatase calcineurin. The target of the FKBP12-rapamycin complex has not yet been identified. We report that a protein complex containing 245 kDa and 35 kDa components, designated rapamycin and FKBP12 targets 1 and 2 (RAFT1 and RAFT2), interacts with FKBP12 in a rapamycin-dependent manner. Sequences (330 amino acids total) of tryptic peptides derived from the 245 kDa RAFT1 reveal striking homologies to the yeast TOR gene products, which were originally identified by mutations that confer rapamycin resistance in yeast. A RAFT1 cDNA was obtained and found to encode a 289 kDa protein (2549 amino acids) that is 43% and 39% identical to TOR2 and TOR1, respectively. We propose that RAFT1 is the direct target of FKBP12-rapamycin and a mammalian homolog of the TOR proteins.
Similar articles
-
Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.J Biol Chem. 1995 Jan 13;270(2):815-22. doi: 10.1074/jbc.270.2.815. J Biol Chem. 1995. PMID: 7822316
-
TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.J Biol Chem. 1995 Nov 17;270(46):27531-7. doi: 10.1074/jbc.270.46.27531. J Biol Chem. 1995. PMID: 7499212
-
Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.Genes Dev. 1996 Feb 1;10(3):279-88. doi: 10.1101/gad.10.3.279. Genes Dev. 1996. PMID: 8595879
-
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.Curr Opin Nephrol Hypertens. 1995 Nov;4(6):472-7. doi: 10.1097/00041552-199511000-00002. Curr Opin Nephrol Hypertens. 1995. PMID: 8591053 Review.
-
Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.Prog Cell Cycle Res. 1995;1:53-71. doi: 10.1007/978-1-4615-1809-9_5. Prog Cell Cycle Res. 1995. PMID: 9552353 Review.
Cited by
-
Structures and Functions of the Human GATOR1 Complex.Subcell Biochem. 2024;104:269-294. doi: 10.1007/978-3-031-58843-3_12. Subcell Biochem. 2024. PMID: 38963491 Review.
-
Tumor biomarkers for diagnosis, prognosis and targeted therapy.Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2. Signal Transduct Target Ther. 2024. PMID: 38763973 Free PMC article. Review.
-
P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth.Oncogene. 2024 Jun;43(24):1813-1823. doi: 10.1038/s41388-024-03032-1. Epub 2024 Apr 23. Oncogene. 2024. PMID: 38654109 Free PMC article.
-
Zebrafish raptor mutation inhibits the activity of mTORC1, inducing craniofacial defects due to autophagy-induced neural crest cell death.Development. 2024 Mar 15;151(6):dev202216. doi: 10.1242/dev.202216. Epub 2024 Mar 21. Development. 2024. PMID: 38512806
-
The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb.Cell Res. 2024 May;34(5):355-369. doi: 10.1038/s41422-024-00938-z. Epub 2024 Mar 6. Cell Res. 2024. PMID: 38448650 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous